In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 28 for your search:
Drug:  imiquimod
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: 0559/07, NCT00803907

2.

Phase: Phase IV
Type: Prevention, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10-0933, NCT01229319

3.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: IPDTAKOTR/V06/28.12.11, NCT01538901

4.

Phase: Phase IV
Type: Diagnostic, Health services research, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 23592103, NCT01663558

5.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: LP0041-63, 2012-003112-31, NCT01926496

6.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Trial Photoderm Graz 2010-1, NCT01088737

7.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ITIC2, NCT01283763

8.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: BRD11/06-S, NCT01720407

9.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: KLI293, NCT01861535

10.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 27 and over
Sponsor: NCI, Other
Protocol IDs: AMC-088, NCI-2013-02288, U01CA121947, NCT02059499

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Luc 10-002, NCT01191034

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NYU 11-00598, 1R01CA161891-01, NCT01421017

13.

Phase: Phase II, Phase I
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: STML-701-0114, NCT02078648

14.

Phase: Phase II
Type: Prevention
Status: Active
Age: 18 to 50
Sponsor: Other
Protocol IDs: _1.0, ISRCTN: 2008-004893-42, NCT00941811

15.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 10-000202, NCT01204684

16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MM1120, NCT01543464

17.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: UbiVac DPV-001, R44CA121612, NCT01909752

18.

Phase: Phase I
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: Pro00000581, P50CA108786, P30CA014236, SPORE Project 3, CDR0000579683, DUMC-PRO00000581, NCT00626483

19.

Phase: Phase I
Type: Treatment
Status: Active
Age: 3 to 25
Sponsor: Other
Protocol IDs: 2009LS136, 1004M81213, NCT01400672

20.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 19814, NCT01792505

21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 100
Sponsor: Other
Protocol IDs: UMIAMI-20110462, NCT01803152

22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 13 to 99
Sponsor: Other
Protocol IDs: UMIAMI-20120750, NCT01808820

23.

Phase: Phase I
Type: Treatment
Status: Active
Age: Over 1 year to less than 30 years
Sponsor: Other
Protocol IDs: UMIAMI-20130136, NCT01902771

24.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: J0656 CDR0000617261, JHOC-J0656, NA_00002176, 2P50CA098252, 1R21CA123876, NCT00788164

25.

Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 01 KI 0211, NCT00365729
1   
New Search